SCHEMBL17855908

SCHEMBL17855908

c1ccc(C2(c3ccccc3)c3ccccc3-c3cc(N(c4ccc(-c5cccc(-c6cccc7c6oc6ccccc67)c5)cc4)c4ccc(-c5cccc(-c6cccc7c6oc6ccccc67)c5)cc4)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
GGPS1 O95749 1/20 0.39
PRKDC P78527 3/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
PLA2G10 O15496 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
OPRK1 P41145 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17855766 0.99 ALOX5 (0.43) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855874 0.99 ALOX5 (0.43) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855839 0.98 ALOX5 (0.42) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17854634 0.97 ALOX5 (0.42) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17854627 0.97 ALOX5 (0.42) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855870 0.96 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855732 0.96 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855903 0.96 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855758 0.96 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL17855656 0.96 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, ESR2, CCNE2 ALOX5 1603/4885GGPS1 3865/4885PRKDC 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.